Skip to main content
. 2014 Dec 23;14:995. doi: 10.1186/1471-2407-14-995

Figure 3.

Figure 3

Kaplan-Meier analysis of breast cancer specific survival showing the impact of low (black line) and high (grey line) calpain-9 expression in patients that did not receive endocrine therapy (A), and in those that did receive endocrine therapy (B); with significance determined using the log-rank test. The numbers shown below the Kaplan-Meier survival curves are the number of patients at risk at the specified month.